Assessment of Side Effects and Symptom Relief in Adults Receiving Palliative Radiotherapy for Cancer at Policlinico Sant Orsola of Bologna

What this Trial Is About

This observational study focuses on adults with malignant tumors receiving palliative radiotherapy at the Radiotherapy Unit of Sant Orsola Hospital. It aims to evaluate outcomes such as symptom resolution or relief following radiation treatment, considering various tumors, treatment settings, dosages, and techniques used for both newly diagnosed and previously treated cases. The research highlights the role of radiotherapy in alleviating symptoms like pain, bleeding, and obstruction, especially in advanced cancer stages. Participants receive palliative radiotherapy tailored to their tumor type, location, and symptoms, with treatment plans varying in dosage, fractionation, and technique. The study involves systematic data collection on treatment approaches, toxicities, and patient characteristics over an observation period from January 2000 to December 2027. Both retrospective and prospective data contribute to understanding how different radiotherapy methods impact symptom control and side effects. During the study, participants are monitored for symptom improvement, acute and late toxicities, and overall survival up to 12 months after therapy. Assessments include follow-up visits to evaluate symptom-free survival and potential need for retreatment. The study collects information on patient outcomes and side effects related to radiation, supporting a thorough evaluation of palliative radiotherapy effectiveness and safety over time.

Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna.